Tax Management India. Com
Law and Practice  :  Digital eBook
Research is most exciting & rewarding
  TMI - Tax Management India. Com
Follow us:
  Facebook   Twitter   Linkedin   Telegram

Home Case Index All Cases Central Excise Central Excise + AT Central Excise - 2020 (4) TMI AT This

  • Login
  • Cases Cited
  • Summary

Forgot password       New User/ Regiser

⇒ Register to get Live Demo



 

2020 (4) TMI 196 - AT - Central Excise


Issues:
Challenge to order-in-original regarding CENVAT credit availed by a pharmaceutical company, requirement to reverse CENVAT credit for exempted goods, applicability of Rule 6(3) and Rule 6(6) under CENVAT Credit Rules.

Analysis:

1. The appellant, a pharmaceutical manufacturer, challenged an order-in-original issued by the Commissioner of Customs and Central Excise regarding CENVAT credit availed on inputs used for dutiable and exempted products. The appellant claimed to have not availed any common inputs credit and only took credit based on actual consumption for dutiable goods or exported exempted goods.

2. The appellant explained their manufacturing process, emphasizing the specific input-output correlation for each batch of drugs manufactured, known as the consumption coefficient. They asserted that credit was availed only on the quantity of inputs used for dutiable or exported exempted goods, calculated as per the consumption coefficient.

3. The show-cause notice alleged that the appellant failed to maintain separate accounts for dutiable and exempted products, necessitating a reversal of 6% of the value of exempted goods. The demand for reversal of CENVAT credit, along with interest and penalties, was confirmed in the impugned order.

4. The appellant argued that previous decisions by the Tribunal and the High Court supported their position, stating that no reversal of CENVAT credit was required for exempted goods exported under bond. They relied on the interpretation of Rule 6(6) of the CENVAT Credit Rules to support their claim.

5. After considering the arguments and perusing the records, the Tribunal noted the unique nature of the pharmaceutical industry where inputs could be used for various products. The Tribunal found that the appellant had not availed common input credit and had only taken credit based on the actual usage for dutiable or exported exempted goods.

6. The Tribunal referred to the decision of the Hon'ble High Court of Bombay in a similar context, highlighting the applicability of Rule 6(6) of the CENVAT Credit Rules to exempted goods exported under specific conditions. The Tribunal concluded that the appellant was not required to reverse CENVAT credit as they had followed the prescribed procedures and had not availed common input credit.

7. Based on the above analysis, the Tribunal set aside the impugned order, allowing the appeal with consequential relief. The decision was pronounced in open court at the conclusion of the hearing.

 

 

 

 

Quick Updates:Latest Updates